Arce, E et al. (2006) Individuals with schizophrenia present hypo- and hyperactivation during implicit cueing in an inhibitory task. NeuroImage 32, 704–713.
Bari, A and Robbins, TW (2013) Inhibition and impulsivity: behavioral and neural basis of response control. Progress in Neurobiology 108, 44–79.
Barnes, J and Boubert, L (2008) Executive functions are impaired in patients with Parkinson's disease with visual hallucinations. Journal of Neurology, Neurosurgery and Psychiatry 79, 190–192.
Bhattacharyya, S et al. (2015) Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis. European Neuropsychopharmacology 25, 26–37.
Bhattacharyya, S et al. (2014) Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control. Psychological Medicine 44, 3315–3328.
Borgwardt, SJ et al. (2008) Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biological Psychiatry 64, 966–973.
Botvinick, MM et al. (2001) Conflict monitoring and cognitive control. Psychological Review 108, 624–652.
Braet, W et al. (2011) fMRI activation during response inhibition and error processing: the role of the DAT1 gene in typically developing adolescents and those diagnosed with ADHD. Neuropsychologia 49, 1641–1650.
Brown, JW and Braver, TS (2005) Learned predictions of error likelihood in the anterior cingulate cortex. Science 307, 1118–1121.
Carhart-Harris, RL et al. (2016a) The paradoxical psychological effects of lysergic acid diethylamide (LSD). Psychological Medicine 46, 1379–1390.
Carhart-Harris, RL et al. (2013) Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis. Schizophrenia Bulletin 39, 1343–1351.
Carhart-Harris, RL et al. (2016b) Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences of the USA 113, 4853–4858.
Chudasama, Y, Doobay, VM and Liu, Y (2012) Hippocampal-prefrontal cortical circuit mediates inhibitory response control in the rat. Journal of Neuroscience 32, 10915–10924.
Cieslik, EC et al. (2013) Is there ‘one’ DLPFC in cognitive action control? Evidence for heterogeneity from co-activation-based parcellation. Cerebral Cortex 23, 2677–2689.
Corbetta, M, Kincade, JM and Shulman, GL (2002) Neural systems for visual orienting and their relationships to spatial working memory. Journal of Cognitive Neuroscience 14, 508–523.
Daly, E et al. (2014) Response inhibition and serotonin in autism: a functional MRI study using acute tryptophan depletion. Brain 137, 2600–2610.
De Gregorio, D et al. (2016) d-Lysergic acid diethylamide (LSD) as a model of psychosis: mechanism of action and pharmacology. International Journal of Molecular Sciences 17, doi: 10.3390/ijms17111953.
Dolder, PC, Liechti, ME and Rentsch, KM (2015a) Development and validation of a rapid turboflow LC-MS/MS method for the quantification of LSD and 2-oxo-3-hydroxy LSD in serum and urine samples of emergency toxicological cases. Analytical and Bioanalytical Chemistry 407, 1577–1584.
Dolder, PC et al. (2015b) Pharmacokinetics and concentration-effect relationship of oral LSD in humans. International Journal of Neuropsychopharmacology, https://doi.org/10.1093/ijnp/pyv072.
Dolder, PC et al. (2016) LSD acutely impairs fear recognition and enhances emotional empathy and sociality. Neuropsychopharmacology 41, 2638–2646.
du Boisgueheneuc, F et al. (2006) Functions of the left superior frontal gyrus in humans: a lesion study. Brain 129, 3315–3328.
Ford, JM et al. (2004) Acquiring and inhibiting prepotent responses in schizophrenia: event-related brain potentials and functional magnetic resonance imaging. Archives of General Psychiatry 61, 119–129.
Gama, RL et al. (2014) Structural brain abnormalities in patients with Parkinson's disease with visual hallucinations: a comparative voxel-based analysis. Brain and Cognition 87, 97–103.
Geyer, MA and Vollenweider, FX (2008) Serotonin research: contributions to understanding psychoses. Trends in Pharmacological Sciences 29, 445–453.
Godsil, BP et al. (2013) The hippocampal-prefrontal pathway: the weak link in psychiatric disorders? European Neuropsychopharmacolog 23, 1165–1181.
González-Maeso, J and Sealfon, S (2009) Psychedelics and schizophrenia. Trends in Pharmacological Sciences 32, 225–232.
Grossi, D et al. (2011) Do frontal dysfunctions play a role in visual hallucinations in Alzheimer's disease as in Parkinson's disease? A comparative study. Psychology & Neuroscience 4, 385–389.
Halberstadt, AL and Geyer, MA (2013) Serotonergic hallucinogens as translational models relevant to schizophrenia. International Journal of Neuropsychopharmacology 16, 2165–2180.
Hester, R et al. (2008) Human medial frontal cortex activity predicts learning from errors. Cerebral Cortex 18, 1933–1940.
Ibarretxe-Bilbao, N et al. (2010) Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations. Journal of Neurology, Neurosurgery and Psychiatry 81, 650–657.
Johnston, K et al. (2007) Top-down control-signal dynamics in anterior cingulate and prefrontal cortex neurons following task switching. Neuron 53, 453–462.
Kaladjian, A et al. (2007) Blunted activation in right ventrolateral prefrontal cortex during motor response inhibition in schizophrenia. Schizophrenia Research 97, 184–193.
Kometer, M et al. (2013) Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations. Journal of Neuroscience 33, 10544–10551.
Kometer, M and Vollenweider, FX (2016) Serotonergic hallucinogen-induced visual perceptual alterations. Current Topics in Behavioral Neurosciences, https://doi:org/10.107/7854_2016_461.
Krus, DM et al. (1963) Differential behavioral responsivity to LSD-25, study in normal and schizophrenic adults. Archives of General Psychiatry 8, 557–563.
Kumari, V et al. (2008) Cortical grey matter volume and sensorimotor gating in schizophrenia. Cortex 44, 1206–1214.
Lawrence, EJ et al. (2009) The neural basis of response inhibition and attention allocation as mediated by gestational age. Human Brain Mapping 30, 1038–1050.
Liechti, ME, Dolder, PC and Schmid, Y (2016) Alterations of consciousness and mystical-type experiences after acute LSD in humans. Psychopharmacology 234, 1499–1510.
Meltzer, HY et al. (2010) Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of Parkinson's disease psychosis. Neuropsychopharmacology 35, 881–892.
Preller, KH et al. (2017) The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation. Current Biology 27, 451–457.
Quednow, BB et al. (2011) Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Neuropsychopharmacology 37, 630–640.
Ramírez-Ruiz, B et al. (2008) Brain response to complex visual stimuli in Parkinson's patients with hallucinations: a functional magnetic resonance imaging study. Movement Disorders 23, 2335–2343.
Roth, BL, Hanizavareh, SM and Blum, AE (2004) Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders. Psychopharmacology 174, 17–24.
Roth, JK et al. (2009) Similar and dissociable mechanisms for attention to internal versus external information. NeuroImage 48, 601–608.
Rubia, K et al. (2001) An fMRI study of reduced left prefrontal activation in schizophrenia during normal inhibitory function. Schizophrenia Research 52, 47–55.
Rubia, K et al. (2003) Right inferior prefrontal cortex mediates response inhibition while mesial prefrontal cortex is responsible for error detection. NeuroImage 20, 351–358.
Rubia, K et al. (2006) Progressive increase of frontostriatal brain activation from childhood to adulthood during event-related tasks of cognitive control. Human Brain Mapping 27, 973–993.
Schmid, Y et al. (2015) Acute effects of lysergic acid diethylamide in healthy subjects. Biological Psychiatry 78, 544–553.
Schmidt, A et al. (2017) Comparative effects of methylphenidate, modafinil and MDMA on response inhibition neural networks in healthy subjects. International Journal of Neuropsychopharmacology 20, 712–720.
Schmidt, A et al. (2013) Inferior frontal cortex modulation with an acute dose of heroin during cognitive control. Neuropsychopharmacology 38, 2231–2239.
Schmitz, N et al. (2006) Neural correlates of executive function in autistic spectrum disorders. Biological Psychiatry 59, 7–16.
Sigurdsson, T and Duvarci, S (2015) Hippocampal-prefrontal interactions in cognition, behavior and psychiatric disease. Frontiers in Systems Neuroscience 9, 190.
Simmonds, DJ, Pekar, JJ and Mostofsky, SH (2008) Meta-analysis of Go/No-go tasks demonstrating that fMRI activation associated with response inhibition is task-dependent. Neuropsychologia 46, 224–232.
Steeds, H, Carhart-Harris, RL and Stone, JM (2015) Drug models of schizophrenia. Therapeutic Advances in Psychopharmacology 5, 43–58.
Štrac, DŠ, Pivac, N and Mück-Šeler, D (2016) The serotonergic system and cognitive function. Translational Neuroscience 7, 35–49.
Studerus, E, Gamma, A and Vollenweider, FX (2010) Psychometric evaluation of the altered states of consciousness rating scale (OAV). PLoS ONE 5, e12412.
Swick, D, Ashley, V and Turken, U (2011) Are the neural correlates of stopping and not going identical? Quantitative meta-analysis of two response inhibition tasks. NeuroImage 56, 1655–1665.
Tully, LM et al. (2014) Impaired cognitive control mediates the relationship between cortical thickness of the superior frontal gyrus and role functioning in schizophrenia. Schizophrenia Research 152, 358–364.
Vollenweider, F et al. (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 9, 3897–3902.
Vollenweider, FX and Geyer, MA (2001) A systems model of altered consciousness: integrating natural and drug-induced psychoses. Brain Research Bulletin 56, 495–507.
Wapner, S and Krus, DM (1960) Effects of lysergic acid diethylamide, and differences between normals and schizophrenics on the Stroop Color-Word Test. Journal of Neuropsychiatry 2, 76–81.
Woo, CW, Krishnan, A and Wager, TD (2014) Cluster-extent based thresholding in fMRI analyses: pitfalls and recommendations. NeuroImage 91, 412–419.
Zhang, G and Stackman, RW (2015) The role of serotonin 5-HT2A receptors in memory and cognition. Frontiers in Pharmacology 6, 225.